arrow
R

Rachael A Evans

university of leicester
H指数:45
被引数:9,969

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluation

比较低剂量口服缓释吗啡在慢性呼吸困难患者中的疗效、成本效益及实施情况:一项随机对照试验和过程评估的概要

2026-05-010
PRE
Large-Scale Psychometric Assessment and Validation of the Modified COVID-19 Yorkshire Rehabilitation Scale Patient-Reported Outcome Measure for Long COVID or Post-COVID Syndrome
2026-01-260
OAAI
The effectiveness and acceptability of face-to-face rehabilitation for patients with Long Covid who were not hospitalised with their acute infection: a mixed-methods study comprising a randomised controlled trial (RCT) with embedded qualitative component

面对面康复治疗对未因急性感染住院的长期新冠患者的疗效和可接受性:一项包含随机对照试验(RCT)和嵌入式定性研究成分的混合方法研究

2026-01-210
PRE
The safety, physiological response and repeatability of the incremental shuttle walk test in survivors of COVID-19

COVID-19幸存者中递增步行试验的安全性、生理反应及可重复性

2025-12-150
PRE
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国的吗啡治疗慢性呼吸困难 (MABEL): 对多站点,平行组,剂量滴定,双盲,随机,安慰剂对照试验的健康经济学评估

2025-11-050
OA
Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study (vol 12, e200450, 2025)

Bennett JL,Fujihara K,Saiz A,Traboulsee AL,Greenberg BM,Weinshenker BG,等。来自SAkuraMoon开放标签扩展研究的视神经脊髓炎谱系障碍患者中萨他利珠单抗的长期疗效与安全性。Neurology® Neuroimmunology Neuroinflamm.(2025)12:e200450。doi:10.1212/NXI.0000000000200494。

2025-11-010
PRE
Immunological associations in post-infective fatigue syndromes including Long COVID—a systematic review and meta-analysis

感染后疲劳综合征中的免疫学关联,包括Long COVID——一项系统评价和荟萃分析

2025-10-270
OAAI
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国慢性呼吸困难 Morphine 治疗(MABEL)研究:一项多中心、平行组、剂量滴定、双盲、随机、安慰剂对照试验

2025-09-280
OAAI
Personalised Exercise Rehabilitation FOR people with Multiple long-term conditions (PERFORM): findings from a process evaluation of a randomised feasibility study

个性化运动康复对多种长期疾病患者的影响(PERFORM):一项随机可行性研究的过程评估发现

2025-09-171
OA
Personalised exercise-rehabilitation for people with multiple long-term conditions (PERFORM): a randomised feasibility study

针对患有多种长期疾病人群的个性化运动康复(PERFORM):一项随机可行性研究

2025-09-171
OA
Impact of pulmonary rehabilitation programme design on effectiveness in COPD: a systematic review and component network meta-analysis

COPD患者肺康复计划设计对效果的影响:一项系统综述和组分网络Meta分析

2025-08-200
PREAI
The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies

O’Mahoney, L.L.; Routen, A.; Gillies, C.; Jenkins, S.A.; Almaqhawi, A.; Ayoubkhani, D.; Banerjee, A.; Brightling, C.; Calvert, M.; Cassambai, S.; 等. 长期新冠症状的风险:一项针对受控研究的系统评价和荟萃分析。Nat. Commun. 2025, 16, 4249. [Google Scholar] [CrossRef] [PubMed]

2025-05-070
OAAI
Multimorbidity clusters and their associations with health-related quality of life in two UK cohorts
2025-01-080
OAAI